Sign in

CIK 0001279704 · Non-accelerated filer<br>Smaller reporting company

Cellectar Biosciences, Inc.

Sign in to watch
Ticker
CLRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
043321804
Phone
(608) 441-8120
Business address
100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
Former names
NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
  1. UPLOAD Other SEC-generated Letter
  2. 8-K Event Regulation FD disclosure
  3. S-1 Offering Registration Statement
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. DEF 14A Proxy Proxy Statement
  7. 10-K Report Annual Report
  8. 8-K Event Results of operations
  9. 4/A Derivatives Options or other derivatives
  10. 4/A Derivatives Options or other derivatives
  11. 4/A Derivatives Options or other derivatives
  12. 8-K Event Regulation FD disclosure
  13. 8-K Event Regulation FD disclosure
  14. SC 13G/A Stake Amended Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. SC 13G/A Stake Amended Statement of Ownership
  18. SC 13G/A Stake Amended Statement of Ownership
  19. 4 Grant or award Chief Financial Officer acquired 10,000 shares (grant or award)
  20. 4 Grant or award Chief Business Officer acquired 40,000 shares (grant or award)

Page 20 of 61 · 1,218 filings